Navigation Links
TargetScan Evaluation is Shown to Deliver Potentially Higher Cancer Detection Rate and More Accurate Assessment of Grade

ST. LOUIS, Nov. 24 /PRNewswire/ -- A study released recently in the British Journal of Urology detailed the results from biopsies of 140 men who received care at Washington University in St. Louis, Duke University, and the University of Michigan. The study, titled "Evaluation of a novel precision template-guided biopsy system for detecting prostate cancer," found that TargetScan(R) template guided biopsy technology potentially produces a higher cancer detection rate and more accurate assessment of grade.

The TargetScan system combines 3-D image acquisition with a stationary probe, which helps physicians plan and execute targeted prostate biopsies through accurate needle placement within a template, which in turn, can provide confidence in identifying locations of significant cancer in the prostate.

"As physicians we are challenged to provide accurate diagnosis and define the true extent of the disease so we don't over or underestimate the significance of the cancer," said Dr. Gerald Andriole, Professor and Chief of Urology at Washington University in St Louis School of Medicine, a member of the multi-center team that conducted the evaluation of TargetScan. The study's lead author, Dr. Adam Kibel, also from Washington University, agrees. "This technology allows physicians to accurately biopsy the prostate since the location of each biopsy is calculated on the basis of the prostate's size and shape. This may allow us to more accurately find and define the disease. This may allow better monitoring of patients on active surveillance. Importantly, since the location of each biopsy site is recorded, re-biopsy or treatments can be performed with more precision."

TargetScan Touch(TM) is the most current system based on the TargetScan technology platform. TargetScan Touch was unveiled recently at the 2008 American Society for Therapeutic Radiology and Oncology annual meeting, and has been tested at several of the nation's leading medical centers.

TargetScan technology is developed by Envisioneering Medical Technologies in St. Louis, under the guidance of physicians at Washington University in St. Louis. "Traditional hand-manipulated devices allow the prostate gland to shift, which impedes accurate biopsy and placement accuracy. By stabilizing the prostate, physicians can now detect cancer with greater confidence," said Robert Mills, president, Envisioneering Medical Technologies.

About Envisioneering Medical Technologies

Envisioneering Medical Technologies, based in St. Louis, Mo., is dedicated to creating the standard for prostate cancer care by developing technology for improving prostate cancer diagnosis and treatment precision and effectively managing patients throughout the continuum of care. For more information please visit

KM-0022 A

SOURCE Envisioneering Medical Technologies
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Bartlett Communications Launches Free Website Evaluation Tool for Small to Mid-Sized Businesses
2. Care Improvement Plus Achieves Top Scores for First SNP Evaluation Measures
3. Best Practice Database Provides Key Findings for Biopharma Product Launch Evaluation
4. Quigley Announces Completion of Phase IIb Clinical Study of QR-333 For Diabetic Peripheral Neuropathy on November 25, 2008; Collection and Evaluation of Study Data to Begin Immediately Thereafter
5. VA Announces Expansion of Disability Evaluation System Pilot
6. DIA/FDA/PhRMA Drug Safety Conference: Planning the Lifecycle of Safety Evaluation
7. Study sees need for standardized evaluation of antibody response to HIV-1
8. Hooper Holmes Announces Sale of Claims Evaluation Division
9. Syntermed licenses Emory imaging technology for improved evaluation of heart failure patients
10. Dartmouth-Hitchcock Medical Center Evaluation Findings Demonstrate Masimo Patient SafetyNet(TM) Delivers Improvements in Clinical Outcomes and Patient Safety on General Care Floors
11. Population Health Impact Institute Releases Methods Evaluation Process(TM) (MEP(TM)) Accreditation Standards for Public Comment Period
Post Your Comments:
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... and Markets has announced the addition of the ... their offering. ... products and provides an updated review, including its applications ... covering the total market, which includes three main industries: ...
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
Breaking Medicine Technology: